Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 12c/Share

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c